Does the brain accumulate trauma?
Molecular similarities in mice and humans exposed to trauma
post-traumatic stress disorder (PTSD) is a mental illness that can develop after experiencing a traumatic event. Greater awareness of PTSD emerged when large numbers of soldiers returning from the Iraq war reported symptoms. Other traumatic events such as experiencing childhood or sexual abuse, a traffic accident, a natural disaster or violent crime can also lead to PTSD. However, not all individuals who experience a traumatic event will go on to develop PTSD.
In a recently published study, scientists at the Max Planck Institute of Psychiatry sought to better understand the molecular mechanisms of PTSD. Published in the journal Translational Psychiatry, the scientists used both human samples and mouse models to elegantly show that there may be a molecular trace left behind by exposure to trauma.
In a collaboration between the Binder and Chen departments, the scientists investigated the role of a transcription factor named GILZ (glucocorticoid-induced leucine zipper). GILZ is encoded by the Tsc22d3 gene located on the X chromosome and is upregulated by glucocorticoids and a known anti-inflammatory.
Blood samples from the Grady trauma project, a cohort of low-income American civilians who have been exposed to high levels of trauma, were used to measure levels of GILZ mRNA and methylation.
In mice, two different stressors were used to model different timepoints in life. One model stressor biologically stimulates activation of the central stress response prenatally and the other causes PTSD-like behaviour in adulthood.
Director Elisabeth Binder summarises the findings from the human samples: “Interestingly, in men, we saw a pattern whereby the more traumas the men had been exposed to in their lifetime correlated with lower GILZ mRNA and higher GILZ methylation. As such, we think GILZ might ‘quantify stress’.”
These results were complemented by what the scientists then found in male mice. They reported a threefold increase in the number of mice exhibiting PTSD-like behaviours in those who were exposed to both the prenatal stress and later PTSD induction compared with controls. Furthermore, this greater susceptibility was associated with reduced GILZ mRNA levels and epigenetic changes.
Director Alon Chen explains: “We then went on to investigate what happens in mice when we used a virus to specifically knockdown (reduce) GILZ in the amygdala. We found that nearly 70% of mice with reduced amygdalar GILZ displayed PTSD-like behaviour compared to just 10% of mice without the viral knockdown.”
“These exciting translational findings may help us to identify individuals who are most at risk of PTSD and allow us to implement interventions to avoid further exposure” summarises Binder.
Original publication
Maya A. Lebow, Mariana Schroeder, Michael Tsoory, Dorin Holzman-Karniel, Divya Mehta, Shifra Ben-Dor, Shosh Gil, Bekh Bradley, Alicia K. Smith, Tanja Jovanovic, Kerry J. Ressler, Elisabeth B. Binder & Alon Chen; "Glucocorticoid-induced leucine zipper “quantifies” stressors and increases male susceptibility to PTSD"; Translational Psychiatry; volume 9, Jul 25, 2019
Original publication
Maya A. Lebow, Mariana Schroeder, Michael Tsoory, Dorin Holzman-Karniel, Divya Mehta, Shifra Ben-Dor, Shosh Gil, Bekh Bradley, Alicia K. Smith, Tanja Jovanovic, Kerry J. Ressler, Elisabeth B. Binder & Alon Chen; "Glucocorticoid-induced leucine zipper “quantifies” stressors and increases male susceptibility to PTSD"; Translational Psychiatry; volume 9, Jul 25, 2019
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.